User login
Article Type
Changed
Fri, 05/10/2024 - 09:39
TOPLINE:
Nearly 90% of adults were at risk of developing cardiovascular-kidney-metabolic (CKM) syndrome between 2011 and 2020, according to new research published in JAMA.
METHODOLOGY:
- In 2023, the American Heart Association defined to acknowledge how heart and kidney diseases, diabetes, and obesity interact and are increasingly co-occurring conditions.
- Researchers used data from the National Health and Nutrition Examination Survey between 2011 and 2020.
- More than 10,000 adults over age 20 years were included; all of them received a physical and fasting laboratory measurements and self-reported their cardiovascular disease (CVD) status.
- Researchers created categories for risk, ranging from 0 (no risk factors) to 4, using factors such as kidney disease, obesity, and hypertension.
TAKEAWAY:
- (having metabolic risk factors like hypertension or moderate- to high-risk chronic kidney disease).
- 14.6% met the criteria for advanced stage 3 (very high-risk chronic kidney disease or a high risk for 10-year CVD) and stage 4 CKM syndrome (established CVD) combined.
- Men, adults over age 65 years, and Black individuals were at a greater risk for advanced stages of the CKM syndrome.
- Almost half of people met the criteria for stage 2 (having metabolic risk factors like hypertension or moderate- to high-risk chronic kidney disease).
- 14.6% met the criteria for advanced stage 3 (very high-risk chronic kidney disease or a high risk for 10-year CVD) and stage 4 CKM syndrome (established CVD) combined.
- Men, adults over age 65 years, and Black individuals were at a greater risk for advanced stages of the CKM syndrome.
IN PRACTICE:
“Equitable health care approaches prioritizing CKM health are urgently needed,” the study authors wrote.
SOURCE:
The study was led by Muthiah Vaduganathan, MD, MPH, cardiologist and researcher at Brigham and Women’s Hospital, Harvard Medical School, Boston.
LIMITATIONS:
Established CVD statuses were self-reported. Some data that would indicate advanced CKM stages were not available (eg, cardiac biomarkers, echocardiography, and coronary angiography), which may have led to an underestimation of rates.
DISCLOSURES:
One author received grants from Bristol Myers Squibb–Pfizer outside the submitted work. Dr. Vaduganathan received grants from and was an adviser and committee trial member for various pharmaceutical companies outside the submitted work. The authors reported no other disclosures.
A version of this article appeared on Medscape.com.
Topics
Sections
TOPLINE:
Nearly 90% of adults were at risk of developing cardiovascular-kidney-metabolic (CKM) syndrome between 2011 and 2020, according to new research published in JAMA.
METHODOLOGY:
- In 2023, the American Heart Association defined to acknowledge how heart and kidney diseases, diabetes, and obesity interact and are increasingly co-occurring conditions.
- Researchers used data from the National Health and Nutrition Examination Survey between 2011 and 2020.
- More than 10,000 adults over age 20 years were included; all of them received a physical and fasting laboratory measurements and self-reported their cardiovascular disease (CVD) status.
- Researchers created categories for risk, ranging from 0 (no risk factors) to 4, using factors such as kidney disease, obesity, and hypertension.
TAKEAWAY:
- (having metabolic risk factors like hypertension or moderate- to high-risk chronic kidney disease).
- 14.6% met the criteria for advanced stage 3 (very high-risk chronic kidney disease or a high risk for 10-year CVD) and stage 4 CKM syndrome (established CVD) combined.
- Men, adults over age 65 years, and Black individuals were at a greater risk for advanced stages of the CKM syndrome.
- Almost half of people met the criteria for stage 2 (having metabolic risk factors like hypertension or moderate- to high-risk chronic kidney disease).
- 14.6% met the criteria for advanced stage 3 (very high-risk chronic kidney disease or a high risk for 10-year CVD) and stage 4 CKM syndrome (established CVD) combined.
- Men, adults over age 65 years, and Black individuals were at a greater risk for advanced stages of the CKM syndrome.
IN PRACTICE:
“Equitable health care approaches prioritizing CKM health are urgently needed,” the study authors wrote.
SOURCE:
The study was led by Muthiah Vaduganathan, MD, MPH, cardiologist and researcher at Brigham and Women’s Hospital, Harvard Medical School, Boston.
LIMITATIONS:
Established CVD statuses were self-reported. Some data that would indicate advanced CKM stages were not available (eg, cardiac biomarkers, echocardiography, and coronary angiography), which may have led to an underestimation of rates.
DISCLOSURES:
One author received grants from Bristol Myers Squibb–Pfizer outside the submitted work. Dr. Vaduganathan received grants from and was an adviser and committee trial member for various pharmaceutical companies outside the submitted work. The authors reported no other disclosures.
A version of this article appeared on Medscape.com.
TOPLINE:
Nearly 90% of adults were at risk of developing cardiovascular-kidney-metabolic (CKM) syndrome between 2011 and 2020, according to new research published in JAMA.
METHODOLOGY:
- In 2023, the American Heart Association defined to acknowledge how heart and kidney diseases, diabetes, and obesity interact and are increasingly co-occurring conditions.
- Researchers used data from the National Health and Nutrition Examination Survey between 2011 and 2020.
- More than 10,000 adults over age 20 years were included; all of them received a physical and fasting laboratory measurements and self-reported their cardiovascular disease (CVD) status.
- Researchers created categories for risk, ranging from 0 (no risk factors) to 4, using factors such as kidney disease, obesity, and hypertension.
TAKEAWAY:
- (having metabolic risk factors like hypertension or moderate- to high-risk chronic kidney disease).
- 14.6% met the criteria for advanced stage 3 (very high-risk chronic kidney disease or a high risk for 10-year CVD) and stage 4 CKM syndrome (established CVD) combined.
- Men, adults over age 65 years, and Black individuals were at a greater risk for advanced stages of the CKM syndrome.
- Almost half of people met the criteria for stage 2 (having metabolic risk factors like hypertension or moderate- to high-risk chronic kidney disease).
- 14.6% met the criteria for advanced stage 3 (very high-risk chronic kidney disease or a high risk for 10-year CVD) and stage 4 CKM syndrome (established CVD) combined.
- Men, adults over age 65 years, and Black individuals were at a greater risk for advanced stages of the CKM syndrome.
IN PRACTICE:
“Equitable health care approaches prioritizing CKM health are urgently needed,” the study authors wrote.
SOURCE:
The study was led by Muthiah Vaduganathan, MD, MPH, cardiologist and researcher at Brigham and Women’s Hospital, Harvard Medical School, Boston.
LIMITATIONS:
Established CVD statuses were self-reported. Some data that would indicate advanced CKM stages were not available (eg, cardiac biomarkers, echocardiography, and coronary angiography), which may have led to an underestimation of rates.
DISCLOSURES:
One author received grants from Bristol Myers Squibb–Pfizer outside the submitted work. Dr. Vaduganathan received grants from and was an adviser and committee trial member for various pharmaceutical companies outside the submitted work. The authors reported no other disclosures.
A version of this article appeared on Medscape.com.
Topics
Article Type
Sections
Teambase XML
<?xml version="1.0" encoding="UTF-8"?>
<!--$RCSfile: InCopy_agile.xsl,v $ $Revision: 1.35 $-->
<!--$RCSfile: drupal.xsl,v $ $Revision: 1.7 $-->
<root generator="drupal.xsl" gversion="1.7"> <header> <fileName>167992</fileName> <TBEID>0C050005.SIG</TBEID> <TBUniqueIdentifier>MD_0C050005</TBUniqueIdentifier> <newsOrJournal>News</newsOrJournal> <publisherName>Frontline Medical Communications</publisherName> <storyname/> <articleType>2</articleType> <TBLocation>QC Done-All Pubs</TBLocation> <QCDate>20240509T144720</QCDate> <firstPublished>20240509T153732</firstPublished> <LastPublished>20240509T153732</LastPublished> <pubStatus qcode="stat:"/> <embargoDate/> <killDate/> <CMSDate>20240509T153732</CMSDate> <articleSource/> <facebookInfo/> <meetingNumber/> <byline>Brittany Vargas</byline> <bylineText>BRITTANY VARGAS</bylineText> <bylineFull>BRITTANY VARGAS</bylineFull> <bylineTitleText/> <USOrGlobal/> <wireDocType/> <newsDocType>News</newsDocType> <journalDocType/> <linkLabel/> <pageRange/> <citation/> <quizID/> <indexIssueDate/> <itemClass qcode="ninat:text"/> <provider qcode="provider:imng"> <name>IMNG Medical Media</name> <rightsInfo> <copyrightHolder> <name>Frontline Medical News</name> </copyrightHolder> <copyrightNotice>Copyright (c) 2015 Frontline Medical News, a Frontline Medical Communications Inc. company. All rights reserved. This material may not be published, broadcast, copied, or otherwise reproduced or distributed without the prior written permission of Frontline Medical Communications Inc.</copyrightNotice> </rightsInfo> </provider> <abstract/> <metaDescription>Nearly 90% of participants met the criteria for having a stage of the CKM syndrome, with rates remaining steady throughout the study period.Almost half of peopl</metaDescription> <articlePDF/> <teaserImage/> <teaser>Almost 90% of participants could be classified as stage 1 CKM syndrome, and nearly half met criteria for stage 2, study finds.</teaser> <title>Vast Majority of Adults At Risk for Cardiovascular-Kidney-Metabolic Syndrome</title> <deck/> <disclaimer/> <AuthorList/> <articleURL/> <doi/> <pubMedID/> <publishXMLStatus/> <publishXMLVersion>1</publishXMLVersion> <useEISSN>0</useEISSN> <urgency/> <pubPubdateYear/> <pubPubdateMonth/> <pubPubdateDay/> <pubVolume/> <pubNumber/> <wireChannels/> <primaryCMSID/> <CMSIDs/> <keywords/> <seeAlsos/> <publications_g> <publicationData> <publicationCode>card</publicationCode> <pubIssueName/> <pubArticleType/> <pubTopics/> <pubCategories/> <pubSections/> </publicationData> <publicationData> <publicationCode>chph</publicationCode> <pubIssueName/> <pubArticleType/> <pubTopics/> <pubCategories/> <pubSections/> </publicationData> <publicationData> <publicationCode>fp</publicationCode> <pubIssueName/> <pubArticleType/> <pubTopics/> <pubCategories/> <pubSections/> </publicationData> <publicationData> <publicationCode>im</publicationCode> <pubIssueName/> <pubArticleType/> <pubTopics/> <pubCategories/> <pubSections/> </publicationData> </publications_g> <publications> <term canonical="true">5</term> <term>6</term> <term>15</term> <term>21</term> </publications> <sections> <term canonical="true">39313</term> </sections> <topics> <term>194</term> <term canonical="true">229</term> <term>205</term> <term>255</term> </topics> <links/> </header> <itemSet> <newsItem> <itemMeta> <itemRole>Main</itemRole> <itemClass>text</itemClass> <title>Vast Majority of Adults At Risk for Cardiovascular-Kidney-Metabolic Syndrome</title> <deck/> </itemMeta> <itemContent> <h2>TOPLINE:</h2> <p>Nearly 90% of adults were at risk of developing cardiovascular-kidney-metabolic (CKM) syndrome between 2011 and 2020, according to <a href="https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.6892?guestAccessKey=3797feb1-0b89-4e9a-8654-85c8ae964ffe&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050824">new research</a> published in <em>JAMA</em>.</p> <h2>METHODOLOGY:</h2> <ul class="body"> <li>In 2023, the American Heart Association defined to acknowledge how heart and kidney diseases, diabetes, and obesity interact and are increasingly co-occurring conditions.</li> <li>Researchers used data from the National Health and Nutrition Examination Survey between 2011 and 2020.</li> <li>More than 10,000 adults over age 20 years were included; all of them received a physical and fasting laboratory measurements and self-reported their cardiovascular disease (CVD) status.</li> <li>Researchers created categories for risk, ranging from 0 (no risk factors) to 4, using factors such as kidney disease, obesity, and hypertension.</li> </ul> <h2>TAKEAWAY:</h2> <ul class="body"> <li/> <li><span class="tag metaDescription">Nearly 90% of participants met the criteria for having a stage of the CKM syndrome, with rates remaining steady throughout the study period.Almost half of people met the criteria for stage 2 </span>(having metabolic risk factors like hypertension or moderate- to high-risk chronic kidney disease).</li> <li>14.6% met the criteria for advanced stage 3 (very high-risk chronic kidney disease or a high risk for 10-year CVD) and stage 4 CKM syndrome (established CVD) combined.</li> <li>Men, adults over age 65 years, and Black individuals were at a greater risk for advanced stages of the CKM syndrome.</li> <li>Almost half of people met the criteria for stage 2 (having metabolic risk factors like hypertension or moderate- to high-risk chronic kidney disease).<br/><br/>14.6% met the criteria for advanced stage 3 (very high-risk chronic kidney disease or a high risk for 10-year CVD) and stage 4 CKM syndrome (established CVD) combined.<br/><br/>Men, adults over age 65 years, and Black individuals were at a greater risk for advanced stages of the CKM syndrome.</li> </ul> <h2>IN PRACTICE:</h2> <p>“Equitable health care approaches prioritizing CKM health are urgently needed,” the study authors wrote.</p> <h2>SOURCE:</h2> <p>The study was led by Muthiah Vaduganathan, MD, MPH, cardiologist and researcher at Brigham and Women’s Hospital, Harvard Medical School, Boston.</p> <h2>LIMITATIONS: </h2> <p>Established CVD statuses were self-reported. Some data that would indicate advanced CKM stages were not available (eg, cardiac biomarkers, echocardiography, and coronary angiography), which may have led to an underestimation of rates.</p> <h2>DISCLOSURES:</h2> <p>One author received grants from Bristol Myers Squibb–Pfizer outside the submitted work. Dr. Vaduganathan received grants from and was an adviser and committee trial member for various pharmaceutical companies outside the submitted work. The authors reported no other disclosures.</p> <p> <em>A version of this article appeared on <span class="Hyperlink"><a href="https://www.medscape.com/viewarticle/vast-majority-adults-risk-cardiovascular-kidney-metabolic-2024a10008u9">Medscape.com</a></span>.</em> </p> </itemContent> </newsItem> <newsItem> <itemMeta> <itemRole>teaser</itemRole> <itemClass>text</itemClass> <title/> <deck/> </itemMeta> <itemContent> </itemContent> </newsItem> </itemSet></root>
<!--$RCSfile: InCopy_agile.xsl,v $ $Revision: 1.35 $-->
<!--$RCSfile: drupal.xsl,v $ $Revision: 1.7 $-->
<root generator="drupal.xsl" gversion="1.7"> <header> <fileName>167992</fileName> <TBEID>0C050005.SIG</TBEID> <TBUniqueIdentifier>MD_0C050005</TBUniqueIdentifier> <newsOrJournal>News</newsOrJournal> <publisherName>Frontline Medical Communications</publisherName> <storyname/> <articleType>2</articleType> <TBLocation>QC Done-All Pubs</TBLocation> <QCDate>20240509T144720</QCDate> <firstPublished>20240509T153732</firstPublished> <LastPublished>20240509T153732</LastPublished> <pubStatus qcode="stat:"/> <embargoDate/> <killDate/> <CMSDate>20240509T153732</CMSDate> <articleSource/> <facebookInfo/> <meetingNumber/> <byline>Brittany Vargas</byline> <bylineText>BRITTANY VARGAS</bylineText> <bylineFull>BRITTANY VARGAS</bylineFull> <bylineTitleText/> <USOrGlobal/> <wireDocType/> <newsDocType>News</newsDocType> <journalDocType/> <linkLabel/> <pageRange/> <citation/> <quizID/> <indexIssueDate/> <itemClass qcode="ninat:text"/> <provider qcode="provider:imng"> <name>IMNG Medical Media</name> <rightsInfo> <copyrightHolder> <name>Frontline Medical News</name> </copyrightHolder> <copyrightNotice>Copyright (c) 2015 Frontline Medical News, a Frontline Medical Communications Inc. company. All rights reserved. This material may not be published, broadcast, copied, or otherwise reproduced or distributed without the prior written permission of Frontline Medical Communications Inc.</copyrightNotice> </rightsInfo> </provider> <abstract/> <metaDescription>Nearly 90% of participants met the criteria for having a stage of the CKM syndrome, with rates remaining steady throughout the study period.Almost half of peopl</metaDescription> <articlePDF/> <teaserImage/> <teaser>Almost 90% of participants could be classified as stage 1 CKM syndrome, and nearly half met criteria for stage 2, study finds.</teaser> <title>Vast Majority of Adults At Risk for Cardiovascular-Kidney-Metabolic Syndrome</title> <deck/> <disclaimer/> <AuthorList/> <articleURL/> <doi/> <pubMedID/> <publishXMLStatus/> <publishXMLVersion>1</publishXMLVersion> <useEISSN>0</useEISSN> <urgency/> <pubPubdateYear/> <pubPubdateMonth/> <pubPubdateDay/> <pubVolume/> <pubNumber/> <wireChannels/> <primaryCMSID/> <CMSIDs/> <keywords/> <seeAlsos/> <publications_g> <publicationData> <publicationCode>card</publicationCode> <pubIssueName/> <pubArticleType/> <pubTopics/> <pubCategories/> <pubSections/> </publicationData> <publicationData> <publicationCode>chph</publicationCode> <pubIssueName/> <pubArticleType/> <pubTopics/> <pubCategories/> <pubSections/> </publicationData> <publicationData> <publicationCode>fp</publicationCode> <pubIssueName/> <pubArticleType/> <pubTopics/> <pubCategories/> <pubSections/> </publicationData> <publicationData> <publicationCode>im</publicationCode> <pubIssueName/> <pubArticleType/> <pubTopics/> <pubCategories/> <pubSections/> </publicationData> </publications_g> <publications> <term canonical="true">5</term> <term>6</term> <term>15</term> <term>21</term> </publications> <sections> <term canonical="true">39313</term> </sections> <topics> <term>194</term> <term canonical="true">229</term> <term>205</term> <term>255</term> </topics> <links/> </header> <itemSet> <newsItem> <itemMeta> <itemRole>Main</itemRole> <itemClass>text</itemClass> <title>Vast Majority of Adults At Risk for Cardiovascular-Kidney-Metabolic Syndrome</title> <deck/> </itemMeta> <itemContent> <h2>TOPLINE:</h2> <p>Nearly 90% of adults were at risk of developing cardiovascular-kidney-metabolic (CKM) syndrome between 2011 and 2020, according to <a href="https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.6892?guestAccessKey=3797feb1-0b89-4e9a-8654-85c8ae964ffe&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050824">new research</a> published in <em>JAMA</em>.</p> <h2>METHODOLOGY:</h2> <ul class="body"> <li>In 2023, the American Heart Association defined to acknowledge how heart and kidney diseases, diabetes, and obesity interact and are increasingly co-occurring conditions.</li> <li>Researchers used data from the National Health and Nutrition Examination Survey between 2011 and 2020.</li> <li>More than 10,000 adults over age 20 years were included; all of them received a physical and fasting laboratory measurements and self-reported their cardiovascular disease (CVD) status.</li> <li>Researchers created categories for risk, ranging from 0 (no risk factors) to 4, using factors such as kidney disease, obesity, and hypertension.</li> </ul> <h2>TAKEAWAY:</h2> <ul class="body"> <li/> <li><span class="tag metaDescription">Nearly 90% of participants met the criteria for having a stage of the CKM syndrome, with rates remaining steady throughout the study period.Almost half of people met the criteria for stage 2 </span>(having metabolic risk factors like hypertension or moderate- to high-risk chronic kidney disease).</li> <li>14.6% met the criteria for advanced stage 3 (very high-risk chronic kidney disease or a high risk for 10-year CVD) and stage 4 CKM syndrome (established CVD) combined.</li> <li>Men, adults over age 65 years, and Black individuals were at a greater risk for advanced stages of the CKM syndrome.</li> <li>Almost half of people met the criteria for stage 2 (having metabolic risk factors like hypertension or moderate- to high-risk chronic kidney disease).<br/><br/>14.6% met the criteria for advanced stage 3 (very high-risk chronic kidney disease or a high risk for 10-year CVD) and stage 4 CKM syndrome (established CVD) combined.<br/><br/>Men, adults over age 65 years, and Black individuals were at a greater risk for advanced stages of the CKM syndrome.</li> </ul> <h2>IN PRACTICE:</h2> <p>“Equitable health care approaches prioritizing CKM health are urgently needed,” the study authors wrote.</p> <h2>SOURCE:</h2> <p>The study was led by Muthiah Vaduganathan, MD, MPH, cardiologist and researcher at Brigham and Women’s Hospital, Harvard Medical School, Boston.</p> <h2>LIMITATIONS: </h2> <p>Established CVD statuses were self-reported. Some data that would indicate advanced CKM stages were not available (eg, cardiac biomarkers, echocardiography, and coronary angiography), which may have led to an underestimation of rates.</p> <h2>DISCLOSURES:</h2> <p>One author received grants from Bristol Myers Squibb–Pfizer outside the submitted work. Dr. Vaduganathan received grants from and was an adviser and committee trial member for various pharmaceutical companies outside the submitted work. The authors reported no other disclosures.</p> <p> <em>A version of this article appeared on <span class="Hyperlink"><a href="https://www.medscape.com/viewarticle/vast-majority-adults-risk-cardiovascular-kidney-metabolic-2024a10008u9">Medscape.com</a></span>.</em> </p> </itemContent> </newsItem> <newsItem> <itemMeta> <itemRole>teaser</itemRole> <itemClass>text</itemClass> <title/> <deck/> </itemMeta> <itemContent> </itemContent> </newsItem> </itemSet></root>
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Consolidated Pubs: Do Not Show Source Publication Logo
Use ProPublica
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article